Transcriptomics

Dataset Information

0

Global transcriptional responses to KI-MS2-008 treatment and Myc inactivation via doxycycline addition


ABSTRACT: The Myc/Max heterodimer has crucial roles in normal cellular processes such as cell proliferation, metabolism, apoptosis, and differentiation, but its activity is often deregulated in a majority of human cancers. In an effort to explore alternative modes of Myc perturbation, we identified KI-MS2-008 as a small molecule that binds Max and modulates Myc-driven transcription, and in some cellular contexts, KI-MS2-008 treatment leads to a decrease in c-Myc protein levels. As the Myc/Max heterodimer controls many cellular processes, we expected that treatment with this small molecule would cause changes in the transcriptome. We found that treatment with 10 µM KI-MS2-008 resulted in global alterations in the transcriptome, mimicking direct Myc inactivation with doxycycline in P493-6, a B cell line with a Tet-Off system for c-Myc expression. We also discovered enrichment of various Myc target gene sets in the genes downregulated in response to KI-MS2-008 treatment in P493-6 cells. This trend was also observed in ST486 cells, but not in P3HR1 cells, which were chosen as non-engineered B cell lines that were sensitive and insensitive, respectively, toward KI-MS2-008 in cell viability assays.

ORGANISM(S): Homo sapiens

PROVIDER: GSE107222 | GEO | 2019/03/14

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-03-14 | GSE125863 | GEO
| PRJNA419363 | ENA
2012-11-14 | E-GEOD-42262 | biostudies-arrayexpress
2018-08-20 | GSE115915 | GEO
2014-09-22 | E-GEOD-58570 | biostudies-arrayexpress
2014-09-22 | GSE58570 | GEO
2020-03-18 | GSE124255 | GEO
2013-01-02 | GSE43227 | GEO
2013-01-02 | E-GEOD-43227 | biostudies-arrayexpress
2014-07-07 | E-GEOD-51004 | biostudies-arrayexpress